5.3 C
New York
Thursday, January 15, 2026

TD Cowen maintains Buy rating on Aurinia Pharmaceuticals shares at $11


TD Cowen reiterates Buy rating on Aurinia Pharmaceuticals stock at $11

Related Articles

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe

Latest Articles